BridgeMD
New treatment option for Lung Transplant; Pain
Official title Evaluating the Impact of Cryo-analgesia on Recovery After Double Lung Transplantation
ClinicalTrials.gov ID: NCT06959056
What this study is testing
- What it's testing
- The goal of this pilot trial is to learn whether the use of cryo nerve block and its effect on sensation in the chest alters recovery after bilateral lung transplantation, and to which extent these parameters are influenced. As this study is setup as a pilot study, the main questions it aims to determine the potential impacted parameters as well as their effect sizes, of cryo-analgesia on both short and long term outcomes following bilateral lung transplantation in COPD patients in a European high volume lung transplant centre.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
- At least 18 years of age at the time of signing the Informed Consent Form (ICF)
- Bilateral lung transplantation at UZ Leuven
- Indication for transplantation: End stage chronic obstructive pulmonary disease (COPD)
- Storage of lungs on classic ice, cooled system (LUNGguard® (Paragonix) or X°Port Lung Transport Device (Traferox Technologies Inc.) ) are all...
You likely can't join if
- Unilateral lung transplantation
- Lobar transplantation
- Donor lung reconditioning using ex-vivo lung perfusion (EVLP)
- Combined organ transplantation
- Chronic opioid use pre-operatively
- Participation in an treatment Trial with an investigational medicinal product (IMP) or device (IMD) that could potentially influence the...
See the full eligibility criteria
- Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
- At least 18 years of age at the time of signing the Informed Consent Form (ICF)
- Bilateral lung transplantation at UZ Leuven
- Indication for transplantation: End stage chronic obstructive pulmonary disease (COPD)
- Storage of lungs on classic ice, cooled system (LUNGguard® (Paragonix) or X°Port Lung Transport Device (Traferox Technologies Inc.) ) are all permitted
- Patients that have undergone lung volume reduction or talcage are not a contraindication for participation in the study.
- Unilateral lung transplantation
- Lobar transplantation
- Donor lung reconditioning using ex-vivo lung perfusion (EVLP)
- Combined organ transplantation
- Chronic opioid use pre-operatively
- Participation in an treatment Trial with an investigational medicinal product (IMP) or device (IMD) that could potentially influence the post-operative outcomes of this study
The study team makes the final eligibility decision.
Where it's taking place
- Leuven, Vlaams-Brabant, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Leuven, Vlaams-Brabant, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.